May 17, 2024 – Page 6 – Goldea Capital

Virtu Financial Congratulates Michelle Hosea, Recipient of the Rising Star Award at Women in Finance Asia Awards

Written by Customer Service on May 17, 2024. Posted in Public Companies.

NEW YORK, May 17, 2024 (GLOBE NEWSWIRE) — Virtu Financial, Inc. (Nasdaq:VIRT), a leading provider of global, multi-asset financial services that delivers liquidity and innovative, transparent products across the complete investment cycle to the global markets, is pleased to congratulate Michelle Hosea, Quantitative Strategist, on her Women in Finance Asia 2024 Rising Star Award. In Michelle’s three years at Virtu, she has quickly taken a leadership role on the quantitative and research development team in Asia. From spearheading the calibration of our strategies to holding in depth ‘show and tells’ of our algo technology to buy side clients, her influence on our business continues to grow. “Michelle is the ultimate team player consistently extending her support to our sales and coverage teams and collaborating across business...

NFI subsidiary New Flyer announces contract with BC Transit for 33 battery-electric buses

Written by Customer Service on May 17, 2024. Posted in Public Companies.

WINNIPEG, Manitoba, May 17, 2024 (GLOBE NEWSWIRE) — (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) New Flyer Industries Canada ULC (New Flyer), a subsidiary of NFI Group Inc. (NFI) and leading manufacturer of heavy-duty transit buses, today announced a contract with BC Transit Corporation (BC Transit) for 33 next-generation Xcelsior CHARGE NG™ 40-foot battery-electric buses (BEBs). The contract was added to New Flyer’s firm backlog in 2024 Q2. BC Transit oversees municipal transit services for over 130 communities across the province of British Columbia and has an annual ridership of more than 47 million passenger trips. In 2019, BC Transit announced its Low Carbon Fleet Program, which outlined the agency’s plan to expand its fleet and replace aging fleet vehicles with a focus on reducing greenhouse gases. BC Transit’s current goal...

Psyence Biomed to Participate in the A.G.P. Virtual Healthcare Company Showcase

Written by Customer Service on May 17, 2024. Posted in Public Companies.

NEW YORK, May 17, 2024 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd (Nasdaq:PBM) (“Psyence Biomed” or the “Company”) today announced that management will host 1×1 meetings with investors during the A.G.P. Virtual Healthcare Company Showcase, which is being held May 21, 2024. For more information, or to register: https://allianceg.com/events/. About Psyence Biomed Psyence Biomedical Ltd., a corporation organized under the laws of Ontario, Canada, is the world’s first life science biotechnology company traded on The Nasdaq Stock Market LLC (“Nasdaq”) (Nasdaq:PBM) that is focused on the development of botanical (nature derived, or non-synthetic) psilocybin-based psychedelic medicines. The name “Psyence” combines the words “psychedelics” and “science” to affirm Psyence Biomed’s commitment to an evidence-based approach to innovation...

Village Farms International Applauds Historic Move Toward U.S. Marijuana Rescheduling

Written by Customer Service on May 17, 2024. Posted in Public Companies.

VANCOUVER, British Columbia and ORLANDO, Fla., May 17, 2024 (GLOBE NEWSWIRE) — Village Farms International, Inc. (“Village Farms”) (NASDAQ: VFF) applauds the U.S. Department of Justice’s historic decision to pursue federal rescheduling of marijuana for medical purposes to Schedule III from Schedule I under the Controlled Substances Act (CSA) (the “Rescheduling Proposal”). The Rescheduling Proposal starts a 60-day period for public comment. “We are encouraged by this continued regulatory progress and are actively evaluating multiple parallel strategies that may enable Village Farms to enter the legal U.S. marijuana market. All options are expected to leverage our unmatched cannabis success in Canada, using our advantage as one of the largest and highest quality greenhouse cannabis operations in the world. We will continue to monitor...

XORTX Reprices Balance of Warrants Issued in Connection with October 2021 US IPO

Written by Customer Service on May 17, 2024. Posted in Public Companies.

CALGARY, Alberta, May 17, 2024 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, announces that further to its press releases of March 11 and April 30, 2024, the Company has received TSX Venture Exchange (“TSXV”) approval to amend the terms of the balance of outstanding common share purchase warrants (“Warrants”) that were issued on October 15, 2021. Reference is made to the Company’s press release of October 7, 2022 wherein the Company indicated that the Warrants had been repriced in connection with the October 7, 2022 private placement, however that process was not completed at the time. The re-pricing approval received affects an original...

Chemomab Therapeutics to Participate in Upcoming Scientific Conferences

Written by Customer Service on May 17, 2024. Posted in Public Companies.

TEL AVIV, Israel, May 17, 2024 (GLOBE NEWSWIRE) — Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced upcoming scientific presentations at the Gordon Research Conference on Chemotactic Cytokines and at EASL 2024, the Annual Congress of the European Association for the Study of the Liver. The presentations cover a range of topics, from new preclinical studies further elucidating the roles of the soluble protein target CCL24 and Chemomab’s CCL24 neutralizing antibody CM-101 in fibro-inflammatory disease, to novel translational research designed to support the ongoing clinical development of CM-101 for primary sclerosing cholangitis, a rare and often fatal fibrotic liver disease. The presentations...

Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates

Written by Customer Service on May 17, 2024. Posted in Earnings Releases And Operating Results.

Longer follow up and subset analyses from the pivotal FELIX Phase 2 data to be presented in oral presentations at ASCO and EHA Two patients enrolled in Phase 1 Systemic Lupus Erythematosus (SLE) trial; study on track for initial data end of 2024 Market Authorization Application (MAA) for obe-cel in r/r adult ALL accepted by European Medicines Agency (EMA) Conference call to be held today at 08:30 am EDT/13:30 pm BST: conference call participants should pre-register using the link at the bottom of this press release LONDON, May 17, 2024 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announces its operational and financial results for the first quarter ended March 31, 2024. “We continue to engage with the FDA in...

Ittihad announces Full Year 2023 Financial Results

Written by Customer Service on May 17, 2024. Posted in Earnings Releases And Operating Results.

Transformational year – well positioned for future growth ABU DHABI, United Arab Emirates, May 17, 2024 (GLOBE NEWSWIRE) — Ittihad International Investment LLC (Ittihad), the leading industrial conglomerate in the UAE, today announces its Full Year 2023 Financial Results. Financial Highlights Group Revenue of $2.8 billion (AED10.4 billion) Group Adjusted EBITDA* of $138.7 million (AED509.6 million) Successfully launched a 5NC2 debut Sukuk, raising $350 million Continued focus on deleveraging the business, with gross debt leverage of 5.3x at year end (down from 6.0x as of December 31, 2022), and adjusted net leverage* stood at 3.4x in 2023, down from 3.5x in 2022 Debt repayments for the year amounted to $119 million (AED436.6 million) Strong balance sheet continues to provide capital allocation optionality Net cash...

GameStop Announces First Quarter Preliminary Results

Written by Customer Service on May 17, 2024. Posted in Public Companies.

GRAPEVINE, Texas, May 17, 2024 (GLOBE NEWSWIRE) — GameStop Corp. (NYSE: GME) (“GameStop” or the “Company”) today announced certain preliminary unaudited financial information for the first quarter ended May 4, 2024. On a preliminary basis for the 13-weeks ended May 4, 2024 compared to the 13-weeks ended April 29, 2023: Net sales are expected to be in the range of $0.872 billion to $0.892 billion compared to $1.237 billion in the prior year fiscal quarter. Selling, general and administrative (“SG&A”) expenses are expected to be in the range of $290 million to $300 million, compared to $345.7 million in the prior year fiscal quarter. Net loss is expected to be in the range of $27 million to $37 million, compared to a net loss of $50.5 million in the prior year fiscal quarter. Cash, cash equivalents and marketable securities...

Telix Files Registration Statement for Proposed Initial Public Offering in the United States

Written by Customer Service on May 17, 2024. Posted in Public Companies.

MELBOURNE, Australia, May 17, 2024 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has filed a registration statement on Form F-1 (Registration Statement) with the United States (U.S.) Securities and Exchange Commission (SEC) today (U.S. time) relating to a proposed initial public offering (Offering) of its American Depository Shares (ADSs), representing the Company’s ordinary shares, in the U.S. Telix has applied to list the ADSs on the Nasdaq Global Market under the symbol “TLX”. The number of ordinary shares to be represented by each ADS, the number of ADSs to be offered and the price per ADS for the proposed Offering have not yet been determined. The Offering is subject to market conditions, and there can be no assurance as to whether or when the Offering may be completed. Jefferies,...

Day: May 17, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice